Bryan Love to Drug Costs
This is a "connection" page, showing publications Bryan Love has written about Drug Costs.
Connection Strength
0.848
-
Changes in Cost-Effectiveness for Chronic Hepatitis C Virus Pharmacotherapy: The Case for Continuous Cost-Effectiveness Analyses. J Manag Care Spec Pharm. 2020 Jul; 26(7):879-886.
Score: 0.691
-
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada. Oncologist. 2019 04; 24(4):537-548.
Score: 0.158